Detalhe da pesquisa
1.
Germline variants of DNA repair and immune genes in lymphoma from lymphoma-cancer families.
Int J Cancer;
155(1): 93-103, 2024 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38446987
2.
Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial.
BMC Med;
22(1): 107, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38454451
3.
Antitumor activity and safety of camrelizumab combined with apatinib in patients with relapsed or refractory peripheral T-cell lymphoma: An open-label, multicenter, phase II study.
Front Immunol;
14: 1128172, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081867
4.
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.
Cancer Biol Med;
20(2)2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861439
5.
Long-term outcomes of relmacabtagene autoleucel in Chinese patients with relapsed/refractory large B-cell lymphoma: Updated results of the RELIANCE study.
Cytotherapy;
25(5): 521-529, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36842849
6.
Efficacy and safety of relmacabtagene autoleucel, an anti-CD19 chimeric antigen receptor T cell, in relapsed/refractory B-cell non-Hodgkin's lymphoma: 2-year results of a phase 1 trial.
Bone Marrow Transplant;
58(3): 288-294, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477110
7.
Preliminary efficacy and safety of Relmacabtagene autoleucel (Carteyva) in adults with relapsed/refractory follicular lymphoma in China: A phase I/II clinical trial.
Am J Hematol;
97(12): E436-E438, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36053875
8.
Effectiveness and Safety of Anti-CD19 Chimeric Antigen Receptor-T Cell Immunotherapy in Patients With Relapsed/Refractory Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis.
Front Pharmacol;
13: 834113, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35548364
9.
Successful treatment of a case with synchronous follicular lymphoma and gastric adenocarcinoma with CD19 CAR T cells and literature review.
J Clin Pharm Ther;
47(9): 1466-1470, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35437775
10.
A durable 4-1BB-based CD19 CAR-T cell for treatment of relapsed or refractory non-Hodgkin lymphoma.
Chin J Cancer Res;
34(1): 53-62, 2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35355931
11.
The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma.
Cancers (Basel);
13(17)2021 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503063
12.
Peripheral eosinophil counts predict efficacy of anti-CD19 CAR-T cell therapy against B-lineage non-Hodgkin lymphoma.
Theranostics;
11(10): 4699-4709, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33754022
13.
Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies.
BMC Cancer;
21(1): 198, 2021 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33632155
14.
Relmacabtagene autoleucel (relma-cel) CD19 CAR-T therapy for adults with heavily pretreated relapsed/refractory large B-cell lymphoma in China.
Cancer Med;
10(3): 999-1011, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33382529
15.
The clinical outcomes of fresh versus cryopreserved CD19-directed chimeric antigen receptor T cells in non-Hodgkin lymphoma patients.
Cryobiology;
96: 106-113, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32721392
16.
Time from diagnosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma.
Leuk Lymphoma;
61(12): 2939-2946, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32666852
17.
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups.
Blood Cancer J;
10(7): 74, 2020 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32678074
18.
Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades.
Cancer Med;
9(11): 3765-3774, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32281275
19.
Positron-emission tomography-based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma.
Eur J Cancer;
126: 78-90, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31927165
20.
Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin's Lymphoma.
Mol Ther Oncolytics;
15: 60-68, 2019 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31650026